Growth and sexual maturation in a 2-year, open-label clinical study of lisdexamfetamine dimesylate in children and adolescents with ADHD

被引：0
|
作者：
Otero, I. Hernandez [1 ]
Banaschewski, T. [2 ]
Johnson, M. [3 ]
Nagy, P. [4 ,5 ,6 ]
Soutullo, C. A. [7 ]
Zuddas, A. [8 ]
Yan, B. [9 ]
Coghill, D. R. [10 ]
机构：
[1] Hosp Virgen de la Victoria, Unit Child & Adolescent Mental Hlth USMIJ, Malaga, Spain
[2] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Child & Adolescent Psychiat & Psychotherapy, Mannheim, Germany
[3] Gothenburg Univ, Sahlgrenska Acad, Gillberg Neuropsychiat Ctr, Gothenburg, Sweden
[4] Vadaskert Child & Adolescent Psychiat Hosp, Budapest, Hungary
[5] Vadaskert Child & Adolescent Psychiat Hosp, Outpatient Clin, Budapest, Hungary
[6] Outpatient Clin, Budapest, Hungary
[7] Univ Navarra Clin, Child & Adolescent Psychiat Unit, Dept Psychiat & Med Psychol, Pamplona, Spain
[8] Univ Cagliari, Dept Biomed Sci, Child & Adolescent Neuropsychiat Unit, Cagliari, Italy
[9] Shire, Lexington, MA USA
[10] Univ Dundee, Div Neurosci, Dundee, Scotland
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.1943
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EW0074
引用
收藏
页码：S130 / S130
页数：1
相关论文
共 50 条
  • [1] Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Tobias Banaschewski
    Mats Johnson
    Peter Nagy
    Isabel Hernández Otero
    César A. Soutullo
    Brian Yan
    Alessandro Zuddas
    David R. Coghill
    CNS Drugs, 2018, 32 : 455 - 467
  • [2] Growth and Puberty in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Banaschewski, Tobias
    Johnson, Mats
    Nagy, Peter
    Otero, Isabel Hernandez
    Soutullo, Cesar A.
    Yan, Brian
    Zuddas, Alessandro
    Coghill, David R.
    CNS DRUGS, 2018, 32 (05) : 455 - 467
  • [3] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    Coghill, David R.
    Banaschewski, Tobias
    Nagy, Peter
    Hernandez Otero, Isabel
    Soutullo, Cesar
    Yan, Brian
    Caballero, Beatriz
    Zuddas, Alessandro
    CNS DRUGS, 2017, 31 (07) : 625 - 638
  • [4] Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
    David R. Coghill
    Tobias Banaschewski
    Peter Nagy
    Isabel Hernández Otero
    César Soutullo
    Brian Yan
    Beatriz Caballero
    Alessandro Zuddas
    CNS Drugs, 2017, 31 : 625 - 638
  • [5] Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
    David R. Coghill
    Tobias Banaschewski
    Caleb Bliss
    Brigitte Robertson
    Alessandro Zuddas
    CNS Drugs, 2018, 32 : 85 - 95
  • [6] Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate
    Coghill, David R.
    Banaschewski, Tobias
    Bliss, Caleb
    Robertson, Brigitte
    Zuddas, Alessandro
    CNS DRUGS, 2018, 32 (01) : 85 - 95
  • [7] Cognitive function in children and adolescents with ADHD receiving lisdexamfetamine dimesylate in a 2-year safety study
    Banaschewski, T.
    Zuddas, A.
    Bliss, C.
    Robertson, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S737 - S737
  • [8] Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD
    Adler, Lenard A.
    Lynch, Lauren R.
    Shaw, David M.
    Wallace, Samantha P.
    O'Donnell, Katherine E.
    Ciranni, Michael A.
    Briggie, Alexis M.
    Faraone, Stephen V.
    JOURNAL OF ATTENTION DISORDERS, 2017, 21 (02) : 149 - 157
  • [9] Effects of Open-Label Lisdexamfetamine Dimesylate on Self-Reported Quality of Life in Adults with ADHD
    Brams, Matthew
    Giblin, John
    Gasior, Maria
    Gao, Joseph
    Wigal, Timothy
    POSTGRADUATE MEDICINE, 2011, 123 (03) : 99 - 108
  • [10] Clinical efficacy of lisdexamfetamine dimesylate in children and adolescents with ADHD: a post-hoc analysis
    Zuddas, A.
    Banaschewski, T.
    Lecendreux, M.
    Soutullo, C.
    Johnson, M.
    Anderson, C.
    Civil, R.
    Bloomfield, R.
    Squires, L.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S431 - S431
12345